Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
14 participants
INTERVENTIONAL
2020-08-27
2024-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Measurement of Pulmonary Transit Time by Echocardiography: Comparison With Cardiac MRI
NCT02088320
Exercise Tolerance in Patients With Implanted Left Ventricular Assist Device
NCT05063006
Exercise Oxygen Kinetic and Cardiac Output in Hypertrophic Cardiomyopathy
NCT05754489
A Study of Hemodynamic Cardiopulmonary Exercise for CHD
NCT06566196
Intraoperative Diastolic Function by TDI and STE
NCT03088943
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exercise
Everyone is in this arm
contrast echocardiography
giving echocardiographic contrast and taking echocardiographic images before and after exercise
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
contrast echocardiography
giving echocardiographic contrast and taking echocardiographic images before and after exercise
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Able to give informed consent
Exclusion Criteria
2. Pregnancy/Nursing - as assessed/disclosed by the participant
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vanderbilt University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ken Monahan
Assistant Professor of Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ken Monahan, MD
Role: PRINCIPAL_INVESTIGATOR
VUMC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VHVI
Nashville, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB200429
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.